Spencer E M
J Clin Endocrinol Metab. 1980 Jan;50(1):182-5. doi: 10.1210/jcem-50-1-182.
Because animal experiments have suggested that PRL might regulate the serum somatomedin (SM) concentration, the effect of sustained hyperprolactinemia on the serum SM level was studied in patients with proven pituitary microadenomas. PRL was determined by RIA. SM was measured on the same sample by a human placental membrane radioreceptor assay in which all SMs cross-react. The mean serum SM (+/-SE) in 16 females with elevated PRL levels from 68--21,000 ng/ml was 0.97 +/- 0.08 U/ml. This was not statistically different from that of 29 normal women, (P greater than 0.2). The mean SM for the 3 male patients with serum PRL levels from 570--5,050 ng/ml was in the lower range for normal males. There was no correlation in either group between the serum SM and PRL levels. These results indicate that PRL is not a major regulator of the serum SM concentration in man.
由于动物实验表明催乳素(PRL)可能调节血清生长调节素(SM)浓度,因此我们对确诊为垂体微腺瘤的患者进行了持续性高催乳素血症对血清SM水平影响的研究。采用放射免疫分析法(RIA)测定PRL。对同一样本采用人胎盘膜放射受体分析法测定SM,所有SM均会发生交叉反应。16名PRL水平升高(68 - 21,000 ng/ml)的女性血清SM平均值(±标准误)为0.97 ± 0.08 U/ml。这与29名正常女性相比无统计学差异(P > 0.2)。3名血清PRL水平在570 - 5,050 ng/ml的男性患者的平均SM处于正常男性的较低范围。两组中血清SM与PRL水平均无相关性。这些结果表明,PRL并非人类血清SM浓度的主要调节因子。